MTN-038

A Phase 1, Randomized, Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir.

 

MTN researchers begin safety study of a 90-day vaginal ring containing tenofovir

2019-Jan-16

 

See Also

MTN-038 Protocol

 

MTN-038 Study Page


Source URL: https://mtnstopshiv.org/news/studies/mtn038